Founders Fund Vii Management is an investment fund managing more than $24 billion ran by Neil Pai. There are currently 2 companies in Mr. Pai’s portfolio. The largest investments include AbCellera Biologics and COMPASS Pathways plc, together worth $24 billion.
As of 7th February 2024, Founders Fund Vii Management’s top holding is 3,773,530 shares of AbCellera Biologics currently worth over $21.5 billion and making up 89.8% of the portfolio value.
Relative to the number of outstanding shares of AbCellera Biologics, Founders Fund Vii Management owns more than approximately 0.1% of the company.
In addition, the fund holds 278,880 shares of COMPASS Pathways plc worth $2.44 billion, whose value grew 34.9% in the past six months.
Currently, Founders Fund Vii Management's portfolio is worth at least $24 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Founders Fund Vii Management office and employees reside in San Francisco, California. According to the last 13-F report filed with the SEC, Neil Pai serves as the General Counsel at Founders Fund Vii Management.
The two most similar investment funds to Founders Fund Vii Management are Strs Ohio and Acadian Asset Management. They manage $24 billion and $23.8 billion respectively.
Founders Fund Vii Management’s portfolio is diversified across 1 sector.
Currently, their heaviest sector is Health Care — making up 100.0% of
the total portfolio value.
The fund focuses on investments in the Canada as
50.0% of the portfolio companies
are based in the Canada.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
approximately 0.1% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $1.62 billion.
These positions were updated on February 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| AbCellera Biologics Inc. |
No change
3,773,530
|
$21,546,856,000 | 89.83% |
| COMPASS Pathways plc |
No change
278,880
|
$2,440,200,000 | 10.17% |
| No transactions found | |||
| Showing first 500 out of 2 holdings | |||